One notable feature of the GATT-TRIPS Agreement which has already come into effect is the provision requiring those countries that have not previously provided patent protection for pharmaceutical products or agri-chemical products to start accepting such applications as of January 1, 1995, even though the actual grant of patents on such applications may be delayed for five or ten years depending upon the status of economic development in the country in question. Such applications are colloquially referred to as "black box" applications since once filed no action will be taken on them for several years. We have now been advised that "black box" applications are being accepted in the following countries:
Argentina
India *
Uruguay
Costa Rica
Turkey
India *
Uruguay
Costa Rica
Turkey
The obligation to permit such applications seems to be accepted in Brazil and Egypt but it is not clear what the effect of filing such an application may be since the Patent Offices have not yet adopted specific regulations to deal with applications relating to pharmaceutical or agri-chemical products.
* The situation in India has become complicated by the failure of the Upper House of the Indian legislature to approve the necessary Proclamation. This is discussed further in an article specifically addressing the situation in India.

